CD274 and neoplasm: Compared with anti‐PD‐1 or anti‐programmed death ligand 1 (PD‐L1) monotherapy, intraperitoneal administration of SR‐717 was highly efficacious in the inhibition of tumor growth and in prolonging the overall survival rate.373, 374